Sanofi-Aventis

URI: https://gptkb.org/entity/Sanofi-Aventis
GPTKB entity
Statements (39)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:Aventis
gptkb:Schering_AG
gptkbp:acquired gptkb:Aventis
gptkbp:acquisition gptkb:Amunix_Pharmaceuticals
gptkb:Bioverativ
gptkb:Boehringer_Ingelheim's_animal_health_business
gptkb:Kymab
gptkb:Medi_Gene_AG
gptkb:Provention_Bio
gptkb:Boehringer_Ingelheim's_consumer_health_business
gptkb:Apexigen
gptkb:Syntimmune
gptkb:Ablynx
gptkbp:ceo gptkb:Paul_Hudson
gptkbp:employees around 100,000
gptkbp:founded gptkb:2004
gptkbp:founder gptkb:Sanofi_S._A.
gptkbp:headquarters gptkb:Paris,_France
https://www.w3.org/2000/01/rdf-schema#label Sanofi-Aventis
gptkbp:industry gptkb:drug
gptkbp:part_of gptkb:CAC_40
gptkbp:partnership gptkb:GSK
gptkb:Regeneron_Pharmaceuticals
Translate Bio
gptkbp:products vaccines
diabetes treatments
cardiovascular medications
consumer healthcare products
gptkbp:research_focus gptkb:Company
gptkb:psychologist
oncology
rare diseases
gptkbp:revenue €36 billion (2020)
gptkbp:subsidiary gptkb:Genzyme
gptkb:Sanofi_Pasteur
gptkbp:symbol gptkb:SAN
gptkbp:traded_on gptkb:Euronext_Paris